Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1949 3
1951 2
1952 1
1953 1
1954 1
1955 1
1956 1
1958 2
1959 1
1960 3
1961 7
1962 11
1963 8
1964 5
1965 4
1966 7
1967 5
1968 9
1969 8
1970 15
1971 3
1972 11
1973 24
1974 33
1975 35
1976 29
1977 34
1978 27
1979 42
1980 30
1981 44
1982 49
1983 72
1984 53
1985 57
1986 45
1987 57
1988 50
1989 59
1990 49
1991 64
1992 49
1993 48
1994 38
1995 38
1996 30
1997 32
1998 29
1999 29
2000 40
2001 39
2002 51
2003 49
2004 56
2005 66
2006 66
2007 80
2008 100
2009 108
2010 112
2011 155
2012 164
2013 208
2014 243
2015 296
2016 307
2017 289
2018 295
2019 303
2020 360
2021 382
2022 393
2023 395
2024 163

Text availability

Article attribute

Article type

Publication date

Search Results

5,389 results

Results by year

Filters applied: . Clear all
The following term was ignored: %
The following term was not found in PubMed: 20Hooper
Page 1
Kirsten R. Muller-Vahl.
Müller-Vahl KR. Müller-Vahl KR. Med Cannabis Cannabinoids. 2018 Jun 12;1(1):7. doi: 10.1159/000489140. eCollection 2018 Jun. Med Cannabis Cannabinoids. 2018. PMID: 34676315 Free PMC article. No abstract available.
Targeted Therapies for Kirsten Rat Sarcoma (KRAS) G12C Mutant Metastatic Non-Small-Cell Lung Cancers.
O'Leary C, Murphy G, Yeung Y, Tang M, Jain V, O'Leary CG. O'Leary C, et al. Cancers (Basel). 2023 Nov 25;15(23):5582. doi: 10.3390/cancers15235582. Cancers (Basel). 2023. PMID: 38067288 Free PMC article. Review.
Advancements in targeted therapies have improved outcomes for NSCLC patients in the last decade. Kirsten rat sarcoma virus (KRAS) is a commonly mutated oncogene in NSCLC, contributing to tumorigenesis and proliferation. ...
Advancements in targeted therapies have improved outcomes for NSCLC patients in the last decade. Kirsten rat sarcoma virus (KRAS) is …
Kirsten Ras* oncogene: significance of its discovery in human cancer research.
Tsuchida N, Murugan AK, Grieco M. Tsuchida N, et al. Oncotarget. 2016 Jul 19;7(29):46717-46733. doi: 10.18632/oncotarget.8773. Oncotarget. 2016. PMID: 27102293 Free PMC article. Review.
., a gene able to transform a normal cell into a tumor cell - was introduced in 1969, but the word was not used in the human carcinogenesis literature until much later. Transforming Kras and Hras oncogenes from the Kirsten and Harvey sarcoma viruses were not identified unt …
., a gene able to transform a normal cell into a tumor cell - was introduced in 1969, but the word was not used in the human carcinogenesis …
Invasive mucinous adenocarcinoma of the lung.
Xu L, Li C, Lu H. Xu L, et al. Transl Cancer Res. 2019 Dec;8(8):2924-2932. doi: 10.21037/tcr.2019.11.02. Transl Cancer Res. 2019. PMID: 35117050 Free PMC article. Review.
Difference in immunohistochemical expression levels is present in IMA and invasive non-mucinous adenocarcinomas (INMA). Kirsten rat sarcoma viral oncogene homolog (KRAS) mutations are more frequent in IMAs, while epidermal growth factor receptor (EGFR) mutations are relati …
Difference in immunohistochemical expression levels is present in IMA and invasive non-mucinous adenocarcinomas (INMA). Kirsten rat s …
Targeting KRAS in pancreatic adenocarcinoma: Progress in demystifying the holy grail.
Elhariri A, Alhaj A, Ahn D, Sonbol MB, Bekaii-Saab T, Wu C, Rutenberg MS, Stauffer J, Starr J, Majeed U, Jones J, Borad M, Babiker H. Elhariri A, et al. World J Clin Oncol. 2023 Aug 24;14(8):285-296. doi: 10.5306/wjco.v14.i8.285. World J Clin Oncol. 2023. PMID: 37700806 Free PMC article. Review.
Pancreatic cancer (PC) remains one of the most challenging diseases, with a very poor 5-year overall survival of around 11.5%. Kirsten rat sarcoma virus (KRAS) mutation is seen in 90%-95% of PC patients and plays an important role in cancer cell proliferation, differentiat …
Pancreatic cancer (PC) remains one of the most challenging diseases, with a very poor 5-year overall survival of around 11.5%. Kirsten
Targeting Oncogenic KRAS in Non-Small-Cell Lung Cancer.
Sunaga N, Miura Y, Kasahara N, Sakurai R. Sunaga N, et al. Cancers (Basel). 2021 Nov 26;13(23):5956. doi: 10.3390/cancers13235956. Cancers (Basel). 2021. PMID: 34885068 Free PMC article. Review.
Recent advances in molecular biology and the resultant identification of driver oncogenes have achieved major progress in precision medicine for non-small-cell lung cancer (NSCLC). v-Ki-ras2 Kirsten rat sarcoma viral oncogene (KRAS) is the most common driver in NSCLC, and …
Recent advances in molecular biology and the resultant identification of driver oncogenes have achieved major progress in precision medicine …
Colorectal cancer-derived exosomes and modulation KRAS signaling.
Wan YH, Liu QS, Wan SS, Wang RW. Wan YH, et al. Clin Transl Oncol. 2022 Nov;24(11):2074-2080. doi: 10.1007/s12094-022-02877-w. Epub 2022 Jul 5. Clin Transl Oncol. 2022. PMID: 35789981 Review.
On the other hand, tumor cells may discharge exosomes in response to oncogenic mutations. By Inhibiting signaling pathways, including the Kirsten rat sarcoma virus (KRAS) mechanism, which is important in a variety of cell activities, exosomes have been shown to cause color …
On the other hand, tumor cells may discharge exosomes in response to oncogenic mutations. By Inhibiting signaling pathways, including the …
KRAS mutations as essential promoters of lymphangiogenesis via extracellular vesicles in pancreatic cancer.
Pirlog R, Calin GA. Pirlog R, et al. J Clin Invest. 2022 Jul 15;132(14):e161454. doi: 10.1172/JCI161454. J Clin Invest. 2022. PMID: 35838046 Free PMC article.
Kirsten rat sarcoma virus (KRAS) gene mutations are present in more than 90% of pancreatic ductal adenocarcinomas (PDACs). ...
Kirsten rat sarcoma virus (KRAS) gene mutations are present in more than 90% of pancreatic ductal adenocarcinomas (PDACs). ...
5,389 results